Our Services

All the benefits of genetic science brought
right to the privacy of your home.

Our experienced Care Managers are pleased to provide a high quality of service focused on your preventative healthcare benefits. Our primary commitment is to educate patients on the benefits of genetic testing and how these advances in medical technology can provide valuable info to your family and/or doctors to improve the future of your overall health and wellness. In summary, we want to keep you and your family healthy.


What We Provide

Our current provision includes Pharmacogenomics, Hereditary Cancer Identifications, and Clinical lab testing necessities. Within this purview, our results produce rapid identification of infecting organisms, including respiratory, EIA’s (Enzyme Immunoassays) of multiple urinary toxicologic pharmaceutical compounds and wound cultures.






PGX Testing

PGX’s (Pharmacogenetics Screenings) review the genetic potential for personal interactive adverse reactions between various medication categories, and their interactions within the physiologic parameter. Cardio genetics present genetic testing that’s in first and second stage risks stratifications for patient’s family and personal application. Positive genetic test results then must be followed by physical interaction and counseling.

CGX Testing

CGX’s (Hereditary Cancer Screenings) are assistive tests to identify potential genetic mutations that can place patients and/or family in higher predictive cancer risks. Covering 39 genes linked to Breast, Ovarian, Colorectal, Prostate, Thyroid, Uterine and other major cancers, with or without Lynch syndrome.







UTI Testing

UTI’s (urinary tract infections) with full comprehensive panels, including EIA’s (Enzyme Immunoassays) of multiple urinary toxicologic pharmaceutical compounds and wound cultures. Also present clinical pathways in wounds, diabetic ulcers, athletic injuries, and various dermatologic infirmities which have resulted in multiple pharmaceutical products for external applications; Pain modifiers, stem cells, and wound healing compounds.

Clinical Lab Testing

Lab testing consists of annual patient testing using modern laboratory equipment. This covers the full gamete of general endocrine and other studies dependent on the patient’s medical status, as directed by the patient’s physician. The efficiency and manner in which we do these tests are in keeping with the highest laboratory standards, receiving results within 48 hours of testing. Critical values are immediately reported. Specialized testing or more complicated disease states may require greater result times. Results are reviewed in desired Virtual Portals and can be printed out for personal or physician counseling.

HIPPA

The HIPPA security rule requires covered entities to have implemented security measures to protect ePHI (Patient Health Information). This needs to be available to authorized users, but not improperly accessed or used. There are 3 types of safeguards which all of our entities are covered by, administrative, physical, and technical.



Genetic testing for heart disease

Genetic testing can improve cardiovascular diagnosis, prognosis, and management





Hereditary cardiovascular diseases affect more than 1 in 200 people.

The clinical utility of genetic testing for hereditary cardiovascular disease includes:


Diagnosis

• Confirms a clinical diagnosis and differentiates from other causes
• Fulfills diagnostic criteria for complex heart disorders
• Identifies at-risk family members accurately


Risk stratification

• Identifies patients and family members at highest risk for
arrhythmias, aortic dissections, and myocardial infarction
• Predicts response to pharmacotherapies
• Identifies at-risk family members accurately


Management

• Aids in treatment option decisions (e.g., defibrillator or pacemaker, enzyme therapy, surgery, transplant)
• Guides lifestyle modifications to avoid triggering cardiac events
• May aid in insurance coverage of precision medicines



Genetic testing can make a difference

Genetic testing provides important diagnostic and prognostic information for cardiomyopathies, arrhythmias, aortopathies, and familial hypercholesterolemia.
It can also identify at-risk family members—before life-threatening events occur.



Early identification and treatment can be life-saving

For most hereditary cardiovascular diseases, first-degree family members (parents, siblings, children) have a 50% chance of having the same disease-causing genetic variant.

Once a family’s variant is identified, family members can be tested. Negative results eliminate the need for on-going clinical screening for many. Positive results mean at-risk family members can be monitored and treated early.
It can also identify at-risk family members—before life-threatening events occur.



Genetic testing: An integral component of cardiovascular medicine

A large number of cardiology disorders are hereditary. They're very difficult to diagnose without a genetic test. Genetic testing can also help decide the most effective course of treatment and who else in the family is at risk.




All major cardiology professional societies recommend genetic testing, including:

• American College of Cardiology
• American Heart Association
• Heart Failure Society of America